GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » St Jude Medical Inc (NYSE:STJ) » Definitions » Cash Flow from Operations

St Jude Medical (St Jude Medical) Cash Flow from Operations : $1,092 Mil (TTM As of Sep. 2016)


View and export this data going back to 1977. Start your Free Trial

What is St Jude Medical Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Sep. 2016, St Jude Medical's Net Income From Continuing Operations was $212 Mil. Its Depreciation, Depletion and Amortization was $106 Mil. Its Change In Working Capital was $124 Mil. Its cash flow from deferred tax was $-29 Mil. Its Cash from Discontinued Operating Activities was $0 Mil. Its Asset Impairment Charge was $0 Mil. Its Stock Based Compensation was $23 Mil. And its Cash Flow from Others was $6 Mil. In all, St Jude Medical's Cash Flow from Operations for the three months ended in Sep. 2016 was $442 Mil.


St Jude Medical Cash Flow from Operations Historical Data

The historical data trend for St Jude Medical's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Jude Medical Cash Flow from Operations Chart

St Jude Medical Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,287.00 1,335.00 961.00 1,304.00 1,039.00

St Jude Medical Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 411.00 187.00 150.00 313.00 442.00

St Jude Medical Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

St Jude Medical's Cash Flow from Operations for the fiscal year that ended in Dec. 2015 is calculated as:

St Jude Medical's Cash Flow from Operations for the quarter that ended in Sep. 2016 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,092 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


St Jude Medical  (NYSE:STJ) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

St Jude Medical's net income from continuing operations for the three months ended in Sep. 2016 was $212 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

St Jude Medical's depreciation, depletion and amortization for the three months ended in Sep. 2016 was $106 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

St Jude Medical's change in working capital for the three months ended in Sep. 2016 was $124 Mil. It means St Jude Medical's working capital increased by $124 Mil from Jun. 2016 to Sep. 2016 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

St Jude Medical's cash flow from deferred tax for the three months ended in Sep. 2016 was $-29 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

St Jude Medical's cash from discontinued operating Activities for the three months ended in Sep. 2016 was $0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

St Jude Medical's asset impairment charge for the three months ended in Sep. 2016 was $0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

St Jude Medical's stock based compensation for the three months ended in Sep. 2016 was $23 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

St Jude Medical's cash flow from others for the three months ended in Sep. 2016 was $6 Mil.


St Jude Medical Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of St Jude Medical's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


St Jude Medical (St Jude Medical) Business Description

Traded in Other Exchanges
N/A
Address
St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician pro
Executives
Jeff Fecho officer: VP, Global Quality ONE ST. JUDE MEDICAL DRIVE ST. PAUL MN 55117
Philip Ebeling officer: VP, Chief Technology Officer INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
Donald Zurbay officer: VP Finance and CFO C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Michael A Rocca director C/O LIGAND PHARMACEUTICALS INCORPORATED, 10275 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121
Barbara B Hill director
Wendy L Yarno director
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John C Heinmiller officer: Executive Vice President ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
John W Brown director STRYKER CORP, 2725 FAIRFIELD ROAD, KALAMAZOO MI 49002
David C Dvorak director C/O ZIMMER INC, PO BOX 708, WARSAW IN 46580
Michael T Rousseau director, officer: Director, President and CEO ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Eric S Fain officer: Group President ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Daniel J Starks director ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Joel Becker officer: President, Americas ONE ST. JUDE MEDICAL DRIVE, ST. PAUL MN 55418
Rohan Hoare officer: President - NMD 100 CYBERONICS BLVD, HOUSTON TX 77058